eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention.
.the uk�s initial plan had been challenged in court by the
.
"we are calling for the immediate implementation of a statutory duty of candour for the health trusts."
.![]()
.
and parents who refuse to vaccinate their children should consider what they are doing to other young kids in their communities.
.
u.s.
.